✦ LIBER ✦

Combination Therapy with Histone Deacetylase Inhibitors and Lithium Chloride: A Novel Treatment for Carcinoid Tumors

✍ Scribed by Joel T. Adler; Daniel G. Hottinger; Muthusamy Kunnimalaiyaan; Herbert Chen

Book ID: 111772584
Publisher: Springer
Year: 2008
Tongue: English
Weight: 335 KB
Volume: 16
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-008-0194-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel combination of suicide gene ther

A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma

✍ Yamamoto, Seiji; Yamano, Tomoki; Tanaka, Maki; Hoon, Dave S B; Takao, Sonshin; M 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 263 KB

37. Combination Therapy With Lithium Chl

37. Combination Therapy With Lithium Chloride and Valproic Acid: A Novel Treatment for Gastrointestinal Neuroendocrine Tumors

✍ Joel T. Adler; Muthusamy Kunnimalaiyaan; Herbert Chen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB

W1839 Combination Therapy with Suberoyl

W1839 Combination Therapy with Suberoyl Bis-Hydroxamic Acid (SBHA) and Lithium Chloride for Gastrointestinal Carcinoid Tumors

✍ Adler, Joel T.; Hottinger, Daniel G.; Kunnimalaiyaan, Muthusamy; Chen, Herbert 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Combining PCI-24781, a Novel Histone Dea

Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, with Chemotherapy for the Treatment of Soft Tissue Sarcoma

✍ Lopez, G.; Liu, J.; Ren, W.; Wei, W.; Wang, S.; Lahat, G.; Zhu, Q.-S.; Bornmann, 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 873 KB

A phase II study of the histone deacetyl

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

✍ Munster, P N; Thurn, K T; Thomas, S; Raha, P; Lacevic, M; Miller, A; Melisko, M; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 401 KB

A phase II study of the histone deacetyl

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

✍ Tripathy, D.; Thara, E. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 120 KB